Kim Han-Bi, Um Ji-Young, Chung Bo-Young, Kim Jin-Cheol, Kang Seok-Young, Park Chun-Wook, Kim Hye-One
Department of Dermatology, College of Medicine, Hallym University, Kangnam Sacred Heart Hospital, Seoul 150-950, Korea.
Biomedicines. 2022 May 7;10(5):1087. doi: 10.3390/biomedicines10051087.
The aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor, is important for xenobiotic metabolism and binds to various endogenous and exogenous ligands present in the skin. AhR is known to be associated with diseases in various organs; however, its functions in chronic inflammatory skin diseases, such as atopic dermatitis (AD) and psoriasis (PS), have recently been elucidated. Here, we discuss the molecular mechanisms of AhR related to chronic inflammatory skin diseases, such as AD and PS, and the mechanisms of action of AhR on the skin immune system. The importance of AhR molecular biological pathways, clinical features in animal models, and AhR ligands in skin diseases need to be investigated. In conclusion, the therapeutic effects of AhR ligands are demonstrated based on the relationship between AhR and skin diseases. Nevertheless, further studies are required to elucidate the detailed roles of AhR in chronic inflammatory skin diseases.
芳基烃受体(AhR)是一种依赖配体的转录因子,对异源物代谢很重要,并且能与皮肤中存在的各种内源性和外源性配体结合。已知AhR与各个器官的疾病有关;然而,其在慢性炎症性皮肤病如特应性皮炎(AD)和银屑病(PS)中的作用最近已得到阐明。在此,我们讨论与AD和PS等慢性炎症性皮肤病相关的AhR的分子机制,以及AhR对皮肤免疫系统的作用机制。AhR分子生物学途径的重要性、动物模型中的临床特征以及皮肤疾病中的AhR配体都需要进行研究。总之,基于AhR与皮肤疾病之间的关系证明了AhR配体的治疗效果。尽管如此,仍需要进一步研究以阐明AhR在慢性炎症性皮肤病中的详细作用。